Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Registry for Hereditary Cancer Risk Assessment and Genetic Testing Among Men With Prostate Cancer in the Community Urology Practice Setting

NCT04015102 is registered in ClinicalTrials.gov with Myriad Genetic Laboratories, Inc. as lead sponsor.

NCT NCT04015102
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04015102 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Registry for Hereditary Cancer Risk Assessment and Genetic Testing Among Men With Prostate Cancer in the Community Urology Practice Setting
Lead sponsor
Myriad Genetic Laboratories, Inc.
Phase
Observational
Overall status
Completed
Start date
March 6, 2019
Completion date
October 30, 2020
Enrollment
255 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer